A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.

A review of nanotechnological approaches for the prophylaxis of HIV/AIDS.
复制标题

DOI:
10.1016/j.biomaterials.2013.05.012
复制
发表时间:
2013-08
期刊:
影响因子:
14
通讯作者:
Destache, Christopher J.
Destache, Christopher J.
中科院分区:
工程技术1区
文献类型:
--
作者:
Date, Abhijit A.;Destache, Christopher J.

文献摘要

参考文献

被引文献

相似文献

成功治疗和控制艾滋病毒/艾滋病是21世纪最大的挑战之一。全世界有3 300多万人感染了艾滋病毒,报告了200多万新的艾滋病毒感染病例。这种情况要求制定有效的预防战略,以控制艾滋病的流行。由于缺乏有效的艾滋病毒疫苗,抗逆转录病毒药物和siRNA等核酸疗法已被用于艾滋病毒预防。临床试验表明,抗逆转录病毒药物、替诺福韦和恩曲他滨可以在一定程度上预防艾滋病毒。然而,完全预防艾滋病毒感染尚未实现。纳米技术在许多疾病的诊断、治疗和预防方面带来了范式转变。目前的综述讨论了各种纳米载体的潜力,如树状大分子、聚合物纳米颗粒、脂质体、脂质纳米载体、药物纳米晶体、无机纳米载体和纳米纤维,以提高各种可用于艾滋病毒预防的方式的疗效。
Successful treatment and control of HIV/AIDS is one of the biggest challenges of 21st century. More than 33 million individuals are infected with HIV worldwide and more than 2 million new cases of HIV infection have been reported. The situation demands development of effective prevention strategies to control the pandemic of AIDS. Due to lack of availability of an effective HIV vaccine, antiretroviral drugs and nucleic acid therapeutics like siRNA have been explored for HIV prophylaxis. Clinical trials shave shown that antiretroviral drugs, tenofovir and emtricitabine can offer some degree of HIV prevention. However, complete prevention of HIV infection has not been achieved yet. Nanotechnology has brought a paradigm shift in the diagnosis, treatment and prevention of many diseases. The current review discusses potential of various nanocarriers such as dendrimers, polymeric nanoparticles, liposomes, lipid nanocarriers, drug nanocrystals, inorganic nanocarriers and nanofibers in improving efficacy of various modalities available for HIV prophylaxis.
DOI: 10.1371/journal.pone.0037410
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Ballard C;Jones E;Gauge N;Aarsland D;Nilsen OB;Saxby BK;Lowery D;Corbett A;Wesnes K;Katsaiti E;Arden J;Amoako D;Prophet N;Purushothaman B;Green D
通讯作者: Green D
DOI: 10.1021/mp800051m
发表时间: 2008-07
影响因子: 4.9
作者:
Alexis F;Pridgen E;Molnar LK;Farokhzad OC
通讯作者: Farokhzad OC
DOI: 10.1016/j.jconrel.2006.02.006
发表时间: 2006-05-15
影响因子: 10.8
作者:
Ataman-Onal, Yasemin;Munier, Severine;Verrier, Bernard
通讯作者: Verrier, Bernard
DOI: 10.1002/jps.22529
发表时间: 2011-08-01
影响因子: 3.8
作者:
Alukda, Dima;Sturgis, Timothy;Youan, Bi-Botti C.
通讯作者: Youan, Bi-Botti C.
DOI: 10.1016/j.ijpharm.2012.07.070
发表时间: 2012-10-15
影响因子: 5.8
作者:
Belletti, Daniela;Tosi, Giovanni;Ruozi, Barbara
通讯作者: Ruozi, Barbara